Table 3

 Progression of heart failure and mortality in randomised controlled trials of post-infarction left ventricular systolic dysfunction

StudyYearHF at baselineDiuretic use at baselineFollow upSubsequent HF eventOverall mortality
HF, heart failure; NA, not available.
SAVE421987–1990∼40%35%42 months15.5%22.5%
CAPRICORN43,441996–1999NA34%15 months13.1%13.6%
EPHESUS411999–200190%60%16 months11.1%15.6%